Johannes W. Nijsen

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Intratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinoma: preliminary results of first use.

Intratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinoma: preliminary results of first use.

Journal: Nuclear medicine communications

Published: January 09, 2018

Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study.

Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 08, 2017

Radioembolization dosimetry: the road ahead.

Radioembolization dosimetry: the road ahead.

Journal: Cardiovascular and interventional radiology

Published: July 22, 2014

Radiation emission from patients treated with holmium-166 radioembolization.

Radiation emission from patients treated with holmium-166 radioembolization.

Journal: Journal of vascular and interventional radiology : JVIR

Published: July 04, 2014

(⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres.

(⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 13, 2013

In vivo dosimetry based on SPECT and MR imaging of 166Ho-microspheres for treatment of liver malignancies.

In vivo dosimetry based on SPECT and MR imaging of 166Ho-microspheres for treatment of liver malignancies.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 19, 2013

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 11, 2013

Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.

Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.

Journal: PloS one

Published: December 27, 2012

The evolution of radioembolisation.

The evolution of radioembolisation.

Journal: The Lancet. Oncology

Published: November 28, 2012

Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.

Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.

Journal: The Lancet. Oncology

Published: August 28, 2012

MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation.

MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation.

Journal: European radiology

Published: May 25, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026